Arginine vasopressin deficiency revealing a disseminated human chorionic gonadotropin-secreting germinoma.
This case emphasizes the importance of investigating the underlying causes of arginine vasopressin deficiency, as timely diagnosis can lead to better management outcomes.
Where it sits
this study against the rest of the desmopressin corpusSummary and findings
A 20-year-old male presented with polyuria and polydipsia, leading to the diagnosis of arginine vasopressin deficiency (AVP-D). Laboratory findings included hypernatremia and elevated serum osmolality, with symptomatic improvement after desmopressin initiation. A transsphenoidal pituitary biopsy confirmed a germinoma secreting human chorionic gonadotropin.
Abstract
Arginine vasopressin deficiency (AVP-D) is an uncommon disorder caused by deficient vasopressin production due to hypothalamic or pituitary gland dysfunction resulting in hypotonic polyuria, whose etiology oftentimes remains elusive. We present the case of a 20-year-old male patient evaluated for polyuria and polydipsia. Laboratory evaluation demonstrated hypernatremia, elevated serum osmolality, and inappropriately dilute urine with symptomatic improvement following initiation of desmopressin, consistent with AVP-D. Initial pituitary magnetic resonance imaging (MRI) showed a small enhancing lesion with pituitary stalk thickening (PST), raising concern for inflammatory or infiltrative etiologies. Extensive autoimmune and pituitary infiltrative disease work-up was unrevealing, and serial imaging remained inconclusive. Given diagnostic uncertainty, a transsphenoidal pituitary biopsy was performed, which proved consistent with a germinoma with evidence of human chorionic gonadotropin secretion. Subsequent staging studies, including spinal MRI and cerebrospinal fluid analysis, raised concern for possible disseminated disease. The patient was treated with craniospinal irradiation and continues close multidisciplinary follow-up for hypopituitarism and AVP-D. This case highlights the need for continued surveillance in patients presenting with AVP-D and nonspecific imaging findings, as early identification of etiology is critical for timely treatment and optimal outcomes.
Background
Arginine vasopressin deficiency (AVP-D) is characterized by inadequate vasopressin production, leading to hypotonic polyuria. Previous literature has noted the challenges in diagnosing the etiology of AVP-D, which can include hypothalamic or pituitary dysfunction. This case is significant as it illustrates the diagnostic journey and the potential for underlying neoplasms, such as germinomas, to present with AVP-D symptoms.
Methods
This is a case report involving a 20-year-old male patient evaluated for polyuria and polydipsia. Diagnostic imaging included pituitary magnetic resonance imaging (MRI) and a transsphenoidal biopsy. The primary outcome was the identification of the underlying cause of AVP-D, with secondary outcomes including symptomatic response to desmopressin.
Results
The patient exhibited hypernatremia and elevated serum osmolality. Following desmopressin treatment, there was symptomatic improvement. The biopsy confirmed a germinoma, which is significant given the patient's initial presentation and the inconclusive imaging results.
Interpretation
This case underscores the importance of considering neoplastic causes in patients with AVP-D, particularly when initial imaging is inconclusive. While desmopressin provided symptomatic relief, the clinical significance of this finding in the context of the underlying tumor requires further investigation. The limitations of a single case report, including the absence of a control group and limited follow-up data, restrict the ability to draw broad conclusions.
Key findings
- Hypernatremia and elevated serum osmolality observed.
- Symptomatic improvement following initiation of desmopressin.
- Transsphenoidal pituitary biopsy consistent with germinoma.
- Evidence of human chorionic gonadotropin secretion from the tumor.
Limitations
- Single case report with no control group.
- Limited follow-up data on patient outcomes.
- No statistical analysis or generalizability.